相关实验视频
Updated: Jun 25, 2025

08:49
Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
16.4K
在炎症性肠病患者的不同患者群体中,术后结果的差异
Ashley Shustak1, Luke Wolfe2, Matthew Ambrosio2
1Department of Colon and Rectal Surgery, Cleveland Clinic Florida, Weston, Florida (Ashley Shustak).
Annals of gastroenterology
|May 23, 2024
概括
由于炎症性肠病 (IBD) 而接受手术的黑人患者面临着更糟糕的术后结果. 这包括比白人或西班牙裔患者更高的感染率,发病率,死亡率和更长的住院时间.
科学领域:
- 手术成果研究的研究结果.
- 关于健康公平性的研究.
- 胃肠病学和肝病学 胃肠学和肝病学
背景情况:
- 炎症性肠病 (IBD) 在美国造成了严重的健康负担.
- 手术干预是管理IBD的常见方法.
- 了解不同患者群体的术后结果至关重要.
研究的目的:
- 评估因IBD而接受手术的不同患者手术后结果的差异.
- 识别特定的并发症及其在不同种族群体的流行率.
- 为改善IBD外科手术中的护理公平的策略提供信息.
主要方法:
- 使用了2016-2018年国家住院样本 (NIS) 数据库.
- 计算了IBD手术患者手术后并发症的国家估计.
- 使用SAS调查程序进行国家估计的统计分析.
主要成果:
- 对107,375名权重患者的分析揭示了人口统计学差异:81.7%的白人,10.1%的黑人,8.2%的西班牙裔.
- 与白人 (3.1%) 和西班牙裔 (2.7%) 患者相比,黑人患者的术后感染率 (4.2%) 较高 (P=0.0137).
- 黑人患者的患病率和死亡率 (20.1%) 显著上升,住院时间更长 (12.6天),尽管并发症较少 (P<0.001).
结论:
- 在IBD手术的术后结果中,种族差异是显而易见的.
- 黑人患者经历了不成比例的更糟糕的结果,包括感染,发病率,死亡率和延长住院时间.
- 建议进一步研究健康的社会决定因素,以解决IBD护理中的不平等问题.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
144
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
144
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease II: Crohn's Disease
217
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
217
Chronic Bowel Disorders: Introduction
442
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
442
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
Inflammatory Bowel Disease I: Ulcerative Colitis
165
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
165

